Document Detail

Quantification of microvascular cerebral blood flux and late-stage tumor compartmentalization in 9L gliosarcoma using flow enhanced MRI.
MedLine Citation:
PMID:  23335424     Owner:  NLM     Status:  Publisher    
Measurements of tumor microvasculature are important to obtain an understanding of tumor angiogenesis and for the evaluation of therapies. In this work, we characterize the evolution of the microvascular flux at different stages of tumor growth in the 9L rat brain tumor model. The absolute quantification of cerebral blood flux is achieved with MRI at 7 T using the flow enhanced signal intensity (FENSI) method. FENSI flux maps were obtained between 5 and 14 days after glioma cell inoculation. Based on cerebral blood flux maps, we highlighted two main stages of tumor growth, below and above 3 mm, presenting distinct flux patterns and vascular properties. No significant difference emerged from the group analysis performed on the data collected at an early developmental stage (tumor size < 3 mm) when compared with healthy tissue. At a late developmental stage (tumor size > 3 mm), we observed a significant decrease in the cerebral blood flux inside the gliosarcoma (-33%, p < 0.01) and compartmentalization of the tumor (p < 0.05). FENSI flux maps delineated a low-flux tumor core (58 ± 17 μL/min/cm(2) ) and higher vascularized regions around the tumor periphery (85 ± 21 μL/min/cm(2) ). Histology was performed on 11 animals to finely probe the intratumor heterogeneity and microvessel density, and the results were compared with the information derived from FENSI flux maps. The hyper- and hypoperfused tumor regions revealed with FENSI at the late tumor developmental stage correlated well with the ratios of high and low blood vessel density (R(2)  = 0.41) and fractional vascular surface (R(2)  = 0.67) observed with fluorescence microscopy [cluster of differentiation 31 (CD31) staining]. Copyright © 2013 John Wiley & Sons, Ltd.
Olivier Reynaud; Françoise Geffroy; Luisa Ciobanu
Related Documents :
24335934 - Treatment outcomes in patients treated with cyberknife radiosurgery for vestibular schw...
18786714 - Occipital interhemispheric approach without excision of tentorium for the tumor in the ...
24303404 - Evaluation of tissue expression and salivary levels of her2/neu in patients with head a...
15643514 - Metastasis of malignant peripheral nerve sheath tumor to free vascularized myocutaneous...
19296524 - Chromosomal aberrations in uvb-induced tumors of immunosuppressed mice.
19110234 - Azacitidine enhances sensitivity of platinum-resistant ovarian cancer cells to carbopla...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-21
Journal Detail:
Title:  NMR in biomedicine     Volume:  -     ISSN:  1099-1492     ISO Abbreviation:  NMR Biomed     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8915233     Medline TA:  NMR Biomed     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 John Wiley & Sons, Ltd.
CEA, DSV, I2BM, NeuroSpin, LRMN, Gif sur Yvette, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Exposure to Carbon Nanotubes Leads to Changes in the Cellular Biomechanics.
Next Document:  Reproducibility of first-pass cardiovascular magnetic resonance myocardial perfusion.